IVERIC bio, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 59 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-08-07: Reporting owner PATEL SAMIR CHANDRAKANT; Form 4; Security Series C Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2013-05-23: Reporting owner PATEL SAMIR CHANDRAKANT; Form 4; Security Series C Preferred Stock; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-08-07 | PATEL SAMIR CHANDRAKANT Director, Officer (President) | 4 | Series C Preferred Stock Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +15,388 23,081 owned after | no price filed | 2013-10-02 | |
| 2013-05-23 | PATEL SAMIR CHANDRAKANT Director, Officer (President) | 4 | Series C Preferred Stock Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +7,693 7,693 owned after | no price filed | 2013-10-02 |